Oligopeptidase B, a missing enzyme in mammals and a potential drug target for trypanosomatid diseases.


Journal

Biochimie
ISSN: 1638-6183
Titre abrégé: Biochimie
Pays: France
ID NLM: 1264604

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 24 07 2019
accepted: 15 10 2019
pubmed: 20 10 2019
medline: 7 1 2020
entrez: 20 10 2019
Statut: ppublish

Résumé

Oligopeptidases B (OPB) belong to the S9 prolyl oligopeptidase family and are expressed in prokaryotes, some eukaryotes and in some higher plants. OPB is not found in any of the mammalian genomes available to date. Evidences indicate that OPB participates in the infections caused by trypanosomatids Trypanosoma cruzi, Leishmania spp. and Trypanosoma brucei spp and therefore it is considered an important virulence factor. Trypanosomatids from the genera Leishmania and Trypanosoma also present other OPB, named OPB2. A more accurate investigation of trypanosomatid OPB sequences brought attention to what could be a third OPB sequence (OPB3). This review aims to discuss biochemical, structural, phylogenetic and functional properties of OPB and its potential as target for the development of drugs against Chagas disease, leishmaniasis and African trypanosomiasis.

Identifiants

pubmed: 31628976
pii: S0300-9084(19)30299-8
doi: 10.1016/j.biochi.2019.10.006
pii:
doi:

Substances chimiques

Protozoan Proteins 0
Virulence Factors 0
Serine Endopeptidases EC 3.4.21.-
oligopeptidase B EC 3.4.21.83

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

207-216

Informations de copyright

Copyright © 2019 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.

Auteurs

Flávia Nader Motta (FN)

Pathogen-Host Interface Laboratory, Department of Cell Biology, University of Brasilia, Brasilia, Brazil; Faculdade de Ceilândia, Universidade de Brasília, Brasília, DF, Brazil. Electronic address: fnmotta@unb.br.

Clênia Dos Santos Azevedo (CDS)

Pathogen-Host Interface Laboratory, Department of Cell Biology, University of Brasilia, Brasilia, Brazil; UMR7245 MCAM, Muséum National d'Histoire Naturelle, CNRS, CP54, 57 Rue Cuvier, Paris, France.

Beatriz Pereira Neves (BP)

Pathogen-Host Interface Laboratory, Department of Cell Biology, University of Brasilia, Brasilia, Brazil.

Carla Nunes de Araújo (CN)

Pathogen-Host Interface Laboratory, Department of Cell Biology, University of Brasilia, Brasilia, Brazil; Faculdade de Ceilândia, Universidade de Brasília, Brasília, DF, Brazil.

Philippe Grellier (P)

UMR7245 MCAM, Muséum National d'Histoire Naturelle, CNRS, CP54, 57 Rue Cuvier, Paris, France.

Jaime Martins de Santana (JM)

Pathogen-Host Interface Laboratory, Department of Cell Biology, University of Brasilia, Brasilia, Brazil.

Izabela Marques Dourado Bastos (IMD)

Pathogen-Host Interface Laboratory, Department of Cell Biology, University of Brasilia, Brasilia, Brazil. Electronic address: dourado@unb.br.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH